These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 34705339)
1. NMR-Based Analysis of Nanobodies to SARS-CoV-2 Nsp9 Reveals a Possible Antiviral Strategy Against COVID-19. Esposito G; Hunashal Y; Percipalle M; Venit T; Dieng MM; Fogolari F; Hassanzadeh G; Piano F; Gunsalus KC; Idaghdour Y; Percipalle P Adv Biol (Weinh); 2021 Dec; 5(12):e2101113. PubMed ID: 34705339 [TBL] [Abstract][Full Text] [Related]
2. Assessing nanobody interaction with SARS-CoV-2 Nsp9. Esposito G; Hunashal Y; Percipalle M; Fogolari F; Venit T; Leonchiks A; Gunsalus KC; Piano F; Percipalle P PLoS One; 2024; 19(5):e0303839. PubMed ID: 38758765 [TBL] [Abstract][Full Text] [Related]
3. A Biochemical and Biophysical Analysis of the Interaction of nsp9 with nsp12 from SARS-CoV-2-Implications for Future Drug Discovery Efforts. Baker DL; Wang B; Wilkinson-White LE; El-Kamand S; Allport TA; Ataide SF; Kwan AH; Artsimovitch I; Cubeddu L; Gamsjaeger R Proteins; 2024 Nov; 92(11):1308-1317. PubMed ID: 38958516 [TBL] [Abstract][Full Text] [Related]
4. A distinct ssDNA/RNA binding interface in the Nsp9 protein from SARS-CoV-2. El-Kamand S; Du Plessis MD; Breen N; Johnson L; Beard S; Kwan AH; Richard DJ; Cubeddu L; Gamsjaeger R Proteins; 2022 Jan; 90(1):176-185. PubMed ID: 34369011 [TBL] [Abstract][Full Text] [Related]
5. A natural product compound inhibits coronaviral replication in vitro by binding to the conserved Nsp9 SARS-CoV-2 protein. Littler DR; Liu M; McAuley JL; Lowery SA; Illing PT; Gully BS; Purcell AW; Chandrashekaran IR; Perlman S; Purcell DFJ; Quinn RJ; Rossjohn J J Biol Chem; 2021 Dec; 297(6):101362. PubMed ID: 34756886 [TBL] [Abstract][Full Text] [Related]
6. Inside-out: Antibody-binding reveals potential folding hinge-points within the SARS-CoV-2 replication co-factor nsp9. Pan Y; Chandrashekaran IR; Tennant L; Rossjohn J; Littler DR PLoS One; 2023; 18(4):e0283194. PubMed ID: 37036856 [TBL] [Abstract][Full Text] [Related]
7. A structural analysis of the nsp9 protein from the coronavirus MERS CoV reveals a conserved RNA binding interface. Mani G; El-Kamand S; Wang B; Baker DL; Ataide SF; Artsimovitch I; Cubeddu L; Gamsjaeger R Proteins; 2024 Mar; 92(3):418-426. PubMed ID: 37929701 [TBL] [Abstract][Full Text] [Related]
8. Nanobody against SARS-CoV-2 non-structural protein Nsp9 inhibits viral replication in human airway epithelia. Venit T; Blavier J; Maseko SB; Shu S; Espada L; Breunig C; Holthoff HP; Desbordes SC; Lohse M; Esposito G; Twizere JC; Percipalle P Mol Ther Nucleic Acids; 2024 Sep; 35(3):102304. PubMed ID: 39281707 [TBL] [Abstract][Full Text] [Related]
9. Coronavirus replication-transcription complex: Vital and selective NMPylation of a conserved site in nsp9 by the NiRAN-RdRp subunit. Slanina H; Madhugiri R; Bylapudi G; Schultheiß K; Karl N; Gulyaeva A; Gorbalenya AE; Linne U; Ziebuhr J Proc Natl Acad Sci U S A; 2021 Feb; 118(6):. PubMed ID: 33472860 [TBL] [Abstract][Full Text] [Related]
10. Structure-based drug repurposing for targeting Nsp9 replicase and spike proteins of severe acute respiratory syndrome coronavirus 2. Chandel V; Sharma PP; Raj S; Choudhari R; Rathi B; Kumar D J Biomol Struct Dyn; 2022 Jan; 40(1):249-262. PubMed ID: 32838660 [TBL] [Abstract][Full Text] [Related]
11. NSP9 of SARS-CoV-2 attenuates nuclear transport by hampering nucleoporin 62 dynamics and functions in host cells. Makiyama K; Hazawa M; Kobayashi A; Lim K; Voon DC; Wong RW Biochem Biophys Res Commun; 2022 Jan; 586():137-142. PubMed ID: 34844119 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of SARS-CoV-2 Nsp9 ssDNA-Binding Activity and Cytotoxic Effects on H838, H1975, and A549 Human Non-Small Cell Lung Cancer Cells: Exploring the Potential of Su HH; Lin ES; Huang YH; Lien Y; Huang CY Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892307 [TBL] [Abstract][Full Text] [Related]
13. Backbone chemical shift assignments for the SARS-CoV-2 non-structural protein Nsp9: intermediate (ms - μs) dynamics in the C-terminal helix at the dimer interface. Buchko GW; Zhou M; Craig JK; Van Voorhis WC; Myler PJ Biomol NMR Assign; 2021 Apr; 15(1):107-116. PubMed ID: 33392924 [TBL] [Abstract][Full Text] [Related]
15. Cryo-EM Structure of an Extended SARS-CoV-2 Replication and Transcription Complex Reveals an Intermediate State in Cap Synthesis. Yan L; Ge J; Zheng L; Zhang Y; Gao Y; Wang T; Huang Y; Yang Y; Gao S; Li M; Liu Z; Wang H; Li Y; Chen Y; Guddat LW; Wang Q; Rao Z; Lou Z Cell; 2021 Jan; 184(1):184-193.e10. PubMed ID: 33232691 [TBL] [Abstract][Full Text] [Related]
16. A Multivalent and Thermostable Nanobody Neutralizing SARS-CoV-2 Omicron (B.1.1.529). Lu Y; Li Q; Fan H; Liao C; Zhang J; Hu H; Yi H; Peng Y; Lu J; Chen Z Int J Nanomedicine; 2023; 18():353-367. PubMed ID: 36700149 [TBL] [Abstract][Full Text] [Related]
17. In silico evaluation of lapachol derivatives binding to the Nsp9 of SARS-CoV-2. Junior NN; Santos IA; Meireles BA; Nicolau MSP; Lapa IR; Aguiar RS; Jardim ACG; José DP J Biomol Struct Dyn; 2022 Aug; 40(13):5917-5931. PubMed ID: 33478342 [TBL] [Abstract][Full Text] [Related]
18. Structural basis for the multimerization of nonstructural protein nsp9 from SARS-CoV-2. Zhang C; Chen Y; Li L; Yang Y; He J; Chen C; Su D Mol Biomed; 2020; 1(1):5. PubMed ID: 34765992 [TBL] [Abstract][Full Text] [Related]